P2-239: A randomized phase III study of carboplatin-gemcitabine (CG) versus carboplatin-paclitaxel (CP) in elderly patients (pts) with advanced non-small cell lung cancer (NSCLC) with emphasis on geriatric assessment and quality of life (QoL): The NVALT-3 study

Authors :: Andrew D. Vincent
Hans J.M. Smit
Otilia Dalesio
Harry J.M. Groen
Jos A. Stigt
Bonne Biesma
M. Wymenga
Source :: Journal of Thoracic Oncology. (8):S667-S668
Publisher :: International Association for the Study of Lung Cancer. Published by Elsevier Inc.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
non-small cell lung cancer (NSCLC)
Geriatric assessment
medicine.disease
Carboplatin/paclitaxel
Carboplatin/Gemcitabine
Quality of life
Internal medicine
medicine
Intensive care medicine
business

Full Text Access

Tools